This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Lithium induced thyroid dysfunction

Authoring team

  • lithium inhibits the secretion of T4 and T3 by poorly understood mechanisms
  • lithium is associated with thyroiditis, goitre, hypothyroidism and possibly hyperthyroidism
    • goitre - the incidence of goitre in patients on treatment with lithium approaches 50%; generally it presents as a smooth enlargement of the thyroid gland and requires no further intervention
    • hypothyroidism - occurs in 20-30% of patients on lithium treatment; responds to treatment with thyroxine; generally not necessary to stop lithium treatment
  • prior to commencing treatment with lithium patients should have a neck examination and thyroid function tests; thyroid function should then be checked every 6-12 months whilst on lithium treatment

Reference:

  1. Prescriber (2002), 13 (10), 50-68.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.